Hugh Johnson Advisors LLC Grows Position in Colgate-Palmolive (CL)

Hugh Johnson Advisors LLC lifted its position in shares of Colgate-Palmolive (NYSE:CL) by 60.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,355 shares of the company’s stock after purchasing an additional 3,899 shares during the quarter. Hugh Johnson Advisors LLC’s holdings in Colgate-Palmolive were worth $754,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Jacobi Capital Management LLC raised its stake in Colgate-Palmolive by 125.5% during the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after buying an additional 803 shares during the last quarter. Krilogy Financial LLC raised its stake in Colgate-Palmolive by 23.0% during the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after buying an additional 289 shares during the last quarter. Hanson & Doremus Investment Management raised its stake in Colgate-Palmolive by 4.5% during the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after buying an additional 70 shares during the last quarter. Captrust Financial Advisors purchased a new position in Colgate-Palmolive during the second quarter valued at $122,000. Finally, AlphaMark Advisors LLC raised its stake in Colgate-Palmolive by 1.5% during the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after buying an additional 25 shares during the last quarter. Institutional investors own 72.83% of the company’s stock.

Colgate-Palmolive (NYSE:CL) opened at $75.64 on Wednesday. Colgate-Palmolive has a one year low of $63.43 and a one year high of $77.27. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42. The firm has a market capitalization of $66,420.00, a price-to-earnings ratio of 29.20, a PEG ratio of 3.21 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same quarter in the previous year, the business earned $0.73 earnings per share. The company’s revenue was up 2.8% on a year-over-year basis. research analysts expect that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.

In related news, CMO Mukul Deoras sold 7,500 shares of Colgate-Palmolive stock in a transaction on Friday, November 10th. The stock was sold at an average price of $73.28, for a total value of $549,600.00. Following the completion of the sale, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at $3,313,501.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jennifer Daniels sold 7,375 shares of Colgate-Palmolive stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $73.18, for a total value of $539,702.50. Following the completion of the sale, the insider now directly owns 38,691 shares of the company’s stock, valued at approximately $2,831,407.38. The disclosure for this sale can be found here. Insiders sold 181,048 shares of company stock valued at $13,168,995 in the last 90 days. Company insiders own 1.02% of the company’s stock.

A number of research analysts have issued reports on CL shares. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research note on Monday, October 23rd. Deutsche Bank started coverage on Colgate-Palmolive in a research note on Wednesday, December 13th. They set a “hold” rating and a $75.00 price objective for the company. Morgan Stanley upgraded Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $75.00 to $84.00 in a research note on Monday, September 25th. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Finally, Stifel Nicolaus set a $73.00 price objective on Colgate-Palmolive and gave the company a “hold” rating in a research note on Sunday, October 29th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $76.51.

ILLEGAL ACTIVITY NOTICE: “Hugh Johnson Advisors LLC Grows Position in Colgate-Palmolive (CL)” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.com-unik.info/2018/01/10/hugh-johnson-advisors-llc-grows-position-in-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit